Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting their business models towards a more collaborative business model and have started to look out for partners, giving rise to Bio analytics focused CROs.

The research study also addresses some of the major issues and challenges alongside providing information on the key unmet needs and emerging trends in the market. The report also outlines market drivers and restraints, market engineering measurements as well as R&D trends. Alongside the challenges and opportunities, a special focus is given on the emerging trends and their importance across the current and future market scenario. The report also highlights some of the major shifts occurring in the CRO and Pharma ecosystem with the emergence of several new and innovative CRO players in the market with a specific focus on niche segments, such as bioanalytics and HEOR amongst others.

Further to this, a detailed information will be provided on support services such as Central laboratory services, Bio analytics and Data management. The report covers the complete life cycle of CRO industry, starting from preclinical trials to post-marketing surveillance. One of the focus areas of this study would be bio analytics services, which is making a big impact in CRO industry. There is a major shift observed across the CRO landscape with several key pharma players now outsourcing their early drug development activities (pre-clinical and early phase research) to some of the leading CRO players in the market which was earlier handled by pharma companies themselves.

Some of the key questions being answered by this report include:
• How will the contract research outsourcing help in drug development by saving time and cost for manufacturers?
• What is the impact of the market growth in different regions?
• Who are the dominant market participants in the CRO market and their market share contribution?
• What are the key market trends observed toward expansion of contract research organizations in drug development across key therapeutic
areas?
• Do the products/services offered today meet customer needs or is additional development needed?
• What are the key segments to look out for and what are the key trends in the market?

Table of Contents

1. Executive Summary
Key Findings
Scope and Segmentation
Market Engineering Measurements
Trends for the CRO Market
Transformation of Industry Ecosystem
Pharmaceutical Outsourcing Value Chain
Transition from Small Molecules to Large Molecules
Biologics vs. Chemical Drugs
Key Technology Trends—BI Embedded in Clinical Trial Informatics on the Rise with Hybrid Business Models
Key Social Media Trend
Game-changing Companies
8 Big Market Themes for CROs
CEO’s Perspective
Key Companies to Watch
3 Big Predictions
2. Market Overview
Market Segmentation
Global R&D Spending—Pharmaceutical Drug Development
Global R&D Market Landscape
Global Market Perspective
CRO Product Development and Commercialization
Global CRO Market Snapshot
Global CRO Market Snapshot by Region
Global CRO Market Attractiveness Matrix
Global CRO Revenue by Clinical Development Stage
Market Segmentation—Percent Revenue by Clinical Development Stage
Market Segmentation—Percent Revenue Forecast by Therapeutic Area
Market Segmentation—Percent Revenue by Region
Global CRO Market—Key Trends and Impact on the Business
eClinical Solutions
eClinical Solutions—Applications and Technologies
Rise of Virtual Business Models
3. Competitive Playbook
New Market Opportunities
Critical Unmet Needs and Game-changing Strategies
Global CRO Industry—Major Stake Holders
Global CRO Competitive Matrix
Merger, Acquisition, and Partnership Assessment
4. Drivers and Restraints—Total CRO Market
Global CRO Market Drivers
Global CRO Market Restraints
5. Forecasts and Trends—Total CRO Market
Market Engineering Measurements
Revenue Forecast
Percent Revenue Forecast by Region
Revenue Forecast by Region
6. Competitive Environment
Competitive Analysis—Market Share
Market Share Analysis
Competitive Environment
Competitive Analysis—Select Key Market Participants
7. CRO Segment Analysis—Pre-clinical Trials Segment
Pre-clinical Trials Segment Overview
Market Engineering Measurements
Revenue Forecast
Pre-clinical Trials Segment Metrics Analysis
Pre-clinical Trials Segment Key Trends
8. Phase I Trials Segment
9. Phase II Trials Segment
10. Phase III Trials Segment
11. Phase IV Trials Segment
12. Data Management Segment
13. Biostatistics Segment
14. Pharmacovigilance Segment
15. Health Economics and Outcomes Research (HEOR) Segment
16. Central Laboratory Testing Segment
17. Analytical Testing Service Segment
18. Analytical Testing Services—cGMP Testing Sub-segment
19. Analytical Testing Services—Bioanalytical Testing Sub-segment
20. Analytical Testing Services Segment—Competitive Environment
21. North America CRO Market Overview
North America Breakdown
Percent Revenue by Clinical Development Stage
Percent Share of Clinical Trials by Therapeutic Services
Percent Revenue by Therapeutic Area
Revenue by Clinical Development Stage
Market Engineering Measurements
Revenue Forecast
Percent Revenue Forecast by Clinical Development Stage
22. North America Segment Analysis by Clinical Development Stage
Pre-clinical and Phase I Trials Revenue Forecast
Phase II and Phase III Trials Revenue Forecast
Phase IV Trials and Pharmacovigilance Revenue Forecast
Biostatistics and Data Management Revenue Forecast
Bioanalytical and Central Laboratory Testing Revenue Forecast
HEOR Segment—Revenue Forecast
Market Share
23. Europe CRO Market Overview
24. Europe Segment Analysis by Clinical Development Stage
25. APAC CRO Market Overview
26. APAC Segment Analysis by Clinical Development Stage
27. ROW CRO Market Overview
28. ROW Segment Analysis by Clinical Development Stage
29. Growth Opportunities for the Global CRO Market
30. The Last Word
3 Big Predictions
Legal Disclaimer
31. Appendix
Market Engineering Methodology
Key Companies to Watch
Global CRO Market—Key Trends and Impact on the Business

Infographic



List of Figures & Charts

1. Total CRO Market: Market Snapshot by Region, Global, 2016–2021
2. Total CRO Market: Game-changing Strategies, Global, 2016
3. Total CRO Market: Competitive Matrix, Global, 2016
4. Total CRO Market: Market Outlook, Global, 2016
5. Total CRO Market: Key Market Drivers, Global, 2017–2021
6. Total CRO Market: Key Market Restraints, Global, 2017–2021
7. Total CRO Market: Market Engineering Measurements, Global, 2016
8. Total CRO Market: Revenue Forecast by Region, Global, 2015–2021
9. Total CRO Market: Competitive Structure, Global, 2016
10. Total CRO Market: Competitive Analysis—Covance, Global, 2016
11. Total CRO Market: Competitive Analysis—QuintilesIMS, Global, 2016
12. Total CRO Market: Competitive Analysis—Charles River Laboratories, Global, 2016
13. Total CRO Market: Competitive Analysis—PPD, Global, 2016
14. Total CRO Market: Competitive Analysis—INC Research, Global, 2016
15. Total CRO Market: Competitive Analysis—ICON plc, Global, 2016
16. Total CRO Market: Competitive Analysis—PARAXEL International, Global, 2016
17. Total CRO Market: Competitive Analysis—PRA Health Sciences, Global, 2016
18. Total CRO Market: Competitive Analysis—inVentiv Health, Global, 2016
19. Total CRO Market: Competitive Analysis—WuXi AppTec, Global, 2016
20. Pre-clinical Trials Segment: Market Engineering Measurements, Global, 2016
21. Phase I Trials Segment: Market Engineering Measurements, Global, 2016
22. Phase II Trials Segment: Market Engineering Measurements, Global, 2016
23. Phase III Trials Segment: Market Engineering Measurements, Global, 2016
24. Phase IV Trials Segment: Market Engineering Measurements, Global, 2016
25. Data Management Segment: Market Engineering Measurements, Global, 2016
26. Biostatistics Segment: Market Engineering Measurements, Global, 2016
27. Pharmacovigilance Segment: Market Engineering Measurements, Global, 2016
28. HEOR Segment: Market Engineering Measurements, Global, 2016
29. Central Laboratory Testing Segment: Market Engineering Measurements, Global, 2016
30. Total CRO Market: Bioanalytical and cGMP Testing Segments, Global, 2016
31. cGMP Testing Sub-segment: Market Engineering Measurements, Global, 2016
32. Bioanalytical Testing Sub-segment: Market Engineering Measurements, Global, 2016
33. Analytical Testing Services Segment: Company Market Share Analysis of Top 7 Participants, Global, 2015
34. Analytical Testing Services Segment: Competitive Structure, Global, 2015
35. Analytical Testing Services Segment: Competitive Analysis—Charles River Laboratories, Global, 2016
36. Analytical Testing Services Segment: Competitive Analysis—Eurofins Scientific, Global, 2016
37. Analytical Testing Services Segment: Competitive Analysis—SGS Life Sciences Services, Global, 2016
38. Analytical Testing Services Segment: Competitive Analysis—PPD, Global, 2016
39. Analytical Testing Services Segment: Competitive Analysis—BioReliance Corporation, Global, 2016
40. Analytical Testing Services Segment: Competitive Analysis—Covance, Global, 2016
41. CRO Market: Market Engineering Measurements, North America, 2016
42. CRO Market: Market Engineering Measurements, Europe, 2016
43. CRO Market: Market Engineering Measurements, APAC, 2016
44. CRO Market: Market Engineering Measurements, ROW, 2016


1. Total CRO Market: Market Engineering Measurements, Global, 2016
2. Total CRO Market: Trends for the CRO Market, Global, 2016
3. Total CRO Market: Game-changing Companies, Global, 2016
4. Total CRO Market: Market Segmentation, Global, 2016
5. Total CRO Market: R&D Spending, Global, 2015–2021
6. Total CRO Market: R&D and Clinical Research Outsourcing Landscape, Global, 2016 and 2021
7. Total CRO Market: Stages of Clinical Development, Global, 2016
8. Total CRO Market: Market Attractiveness by Phase, Global, 2016
9. Total CRO Market: Revenue by Clinical Development Stage, Global, 2016
10. Total CRO Market: Percent Revenue by Clinical Development Stage, Global, 2016
11. Total CRO Market: Percent Share of Clinical Trials by Therapeutic Services, Global, 2016
12. Total CRO Market: Percent Revenue by Therapeutic Area, Global, 2016
13. Total CRO Market: Percent Revenue Forecast by Therapeutic Area, Global, 2021
14. Total CRO Market: Percent Revenue by Region, Global, 2016
15. Total CRO Market: Key Trends and Impact on Business, Global, 2016
16. Total CRO Market: Revenue Forecast, Global, 2015–2021
17. Total CRO Market: Percent Revenue Forecast by Region, Global, 2015–2021
18. Total CRO Market: Percent Revenue by Participants, Global, 2015
19. Pre-clinical Trials Segment: Revenue Forecast, Global, 2015–2021
20. Pre-clinical Trials Segment: Metrics Analysis, Global, 2016
21. Phase I Trials Segment: Revenue Forecast, Global, 2015–2021
22. Phase I Trials Segment: Metrics Analysis, Global, 2016
23. Phase II Trials Segment: Revenue Forecast, Global, 2015–2021
24. Phase II Trials Segment: Metrics Analysis, Global, 2016
25. Phase III Trials Segment: Revenue Forecast, Global, 2015–2021
26. Phase III Trials Segment: Metrics Analysis, Global, 2016
27. Phase IV Trials Segment: Revenue Forecast, Global, 2015–2021
28. Phase IV trials Segment: Metrics Analysis, Global, 2016
29. Data Management Segment: Revenue Forecast, Global, 2015–2021
30. Data Management Segment: Metrics Analysis, Global, 2016
31. Biostatistics Segment: Revenue Forecast, Global, 2015–2021
32. Biostatistics Segment: Metrics Analysis, Global, 2016
33. Pharmacovigilance Segment: Revenue Forecast, Global, 2015–2021
34. Pharmacovigilance Segment: Metrics Analysis, Global, 2016
35. HEOR Segment: Revenue Forecast, Global, 2015–2021
36. HEOR Segment: Metrics Analysis, Global, 2016
37. Central Laboratory Testing Segment: Revenue Forecast, Global, 2015–2021
38. Central Laboratory Testing Segment: Metrics Analysis, Global, 2016
39. Analytical Testing Services Segment: Overview, Global, 2016
40. Analytical Testing Services Segment: Segmentation, Global, 2016
41. Analytical Testing Services Segment: Percent Revenue by Sub-segment, Global, 2016
42. cGMP Testing Sub-segment: Revenue Forecast, Global, 2015–2021
43. cGMP Testing Sub-segment: Metrics Analysis, Global, 2016
44. cGMP Testing Sub-segment: Percent Revenue by Type of Service, Global, 2016
45. Bioanalytical Testing Sub-segment: Revenue Forecast, Global, 2015–2021
46. Bioanalytical Testing Sub-segment: Metrics Analysis, Global, 2016
47. Bioanalytical Testing Sub-segment: Percent Revenue by Type of Service, Global, 2016
48. Analytical Testing Services Segment: Major Participants, Global, 2016
49. Analytical Testing Services Segment: Percent Revenue by Participants, Global, 2015
50. CRO Market: Percent Revenue by Clinical Development Stage, North America, 2016
51. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, North America, 2016
52. CRO Market: Percent Revenue by Therapeutic Area, North America, 2016
53. CRO Market: Revenue by Clinical Development Stage, North America, 2016
54. CRO Market: Revenue Forecast, North America, 2015–2021
55. CRO Market: Percent Revenue Forecast by Clinical Development Stage, North America, 2015–2021
56. Pre-clinical Trials Segment: Revenue Forecast, North America, 2015–2021
57. Phase I Trials Segment: Revenue Forecast, North America, 2015–2021
58. Phase II Trials Segment: Revenue Forecast, North America, 2015–2021
59. Phase III Trials Segment: Revenue Forecast, North America, 2015–2021
60. Phase IV Trials Segment: Revenue Forecast, North America, 2015–2021
61. Pharmacovigilance Segment: Revenue Forecast, North America, 2015–2021
62. Biostatistics Segment: Revenue Forecast, North America, 2015–2021
63. Data Management Segment: Revenue Forecast, North America, 2015–2021
64. Bioanalytical Testing Segment: Revenue Forecast, North America, 2015–2021
65. Central Laboratory Testing Segment: Revenue Forecast, North America, 2015–2021
66. HEOR Segment: Revenue Forecast, North America, 2015–2021
67. CRO Market: Percent Revenue Breakdown, North America, 2015
68. CRO Market: Percent Revenue by Clinical Development Stage, Europe, 2016
69. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, Europe, 2016
70. CRO Market: Percent Revenue by Therapeutic Area, Europe, 2016
71. CRO Market: Revenue by Clinical Development Stage, Europe, 2016
72. CRO Market: Revenue Forecast, Europe, 2015–2021
73. CRO Market: Percent Revenue Forecast by Clinical Development Stage, Europe, 2015–2021
74. Pre-clinical Trials Segment: Revenue Forecast, Europe, 2015–2021
75. Phase I Trials Segment: Revenue Forecast, Europe, 2015–2021
76. Phase II Trials Segment: Revenue Forecast, Europe, 2015–2021
77. Phase III Trials Segment: Revenue Forecast, Europe, 2015–2021
78. Phase IV Trials Segment: Revenue Forecast, Europe, 2015–2021
79. Pharmacovigilance Segment: Revenue Forecast, Europe, 2015–2021
80. Biostatistics Segment: Revenue Forecast, Europe, 2015–2021
81. Data Management Segment: Revenue Forecast, Europe, 2015–2021
82. Bioanalytical Testing Segment: Revenue Forecast, Europe, 2015–2021
83. Central Laboratory Testing Segment: Revenue Forecast, Europe, 2015–2021
84. HEOR Segment: Revenue Forecast, Europe, 2015–2021
85. CRO Market: Percent Revenue by Participants, Europe, 2015
86. CRO Market: Percent Revenue by Clinical Development Stage, APAC, 2016
87. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, APAC, 2016
88. CRO Market: Percent Revenue by Therapeutic Area, APAC, 2016
89. CRO Market: Revenue by Clinical Development Stage, APAC, 2016
90. CRO Market: Revenue Forecast, APAC, 2015–2021
91. CRO Market: Percent Revenue Forecast by Clinical Development Stage, APAC, 2015–2021
92. Pre-clinical Trials Segment: Revenue Forecast, APAC, 2015–2021
93. Phase I Trials Segment: Revenue Forecast, APAC, 2015–2021
94. Phase II Trials Segment: Revenue Forecast, APAC, 2015–2021
95. Phase III Trials Segment: Revenue Forecast, APAC, 2015–2021
96. Phase IV Trials Segment: Revenue Forecast, APAC, 2015–2021
97. Pharmacovigilance Segment: Revenue Forecast, APAC, 2015–2021
98. Biostatistics Segment: Revenue Forecast, APAC, 2015–2021
99. Data Management Segment: Revenue Forecast, APAC, 2015–2021
100. Bioanalytical Testing Segment: Revenue Forecast, APAC, 2015–2021
101. Central Laboratory Testing Segment: Revenue Forecast, APAC, 2015–2021
102. HEOR Segment: Revenue Forecast, APAC, 2015–2021
103. CRO Market: Percent Revenue by Participants, APAC, 2015
104. CRO Market: Percent Revenue by Clinical Development Stage, ROW, 2016
105. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, ROW, 2016
106. CRO Market: Percent Revenue by Therapeutic Area, ROW, 2016
107. CRO Market: Revenue by Clinical Development Stage, ROW, 2016
108. CRO Market: Revenue Forecast, ROW, 2015–2021
109. CRO Market: Percent Revenue Forecast by Clinical Development Stage, ROW, 2015–202
110. Pre-clinical Trials Segment: Revenue Forecast, ROW, 2015–2021
111. Phase I Trials Segment: Revenue Forecast, ROW, 2015–2021
112. Phase II Trials Segment: Revenue Forecast, ROW, 2015–2021
113. Phase III Trials Segment: Revenue Forecast, ROW, 2015–2021
114. Phase IV Trials Segment: Revenue Forecast, ROW, 2015–2021
115. Pharmacovigilance Segment: Revenue Forecast, ROW, 2015–2021
116. Biostatistics Segment: Revenue Forecast, ROW, 2015–2021
117. Data Management Segment: Revenue Forecast, ROW, 2015–2021
118. Bioanalytical Testing Segment: Revenue Forecast, ROW, 2015–2021
119. Central Laboratory Testing Segment: Revenue Forecast, ROW, 2015–2021
120. HEOR Segment: Revenue Forecast, ROW, 2015–2021
121. CRO Market: Percent Revenue Breakdown, ROW, 2015



Keyword1

Keyword2

Keyword3

Related Research

Release Date : 19-Jun-17

Region : Asia Pacific

Release Date : 20-Apr-17

Region : Asia Pacific

Release Date : 23-Mar-17

Region : Asia Pacific

Release Date : 24-Jan-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.